These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10622557)

  • 21. Broadening CD4
    Filskov J; Mikkelsen M; Hansen PR; Christensen JP; Thomsen AR; Andersen P; Bukh J; Agger EM
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell immunity in hepatitis B and hepatitis C virus infection: implications for autoimmunity.
    Ichiki Y; He XS; Shimoda S; Ishibashi H; Keeffe EB; Rossaro L; Gershwin ME
    Autoimmun Rev; 2005 Feb; 4(2):82-95. PubMed ID: 15722254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection.
    Shoukry NH; Grakoui A; Houghton M; Chien DY; Ghrayeb J; Reimann KA; Walker CM
    J Exp Med; 2003 Jun; 197(12):1645-55. PubMed ID: 12810686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is there a role for immune responses in the pathogenesis of hepatitis C?
    Mondelli MU
    J Hepatol; 1996 Aug; 25(2):232-8. PubMed ID: 8878788
    [No Abstract]   [Full Text] [Related]  

  • 27. Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection.
    Wertheimer AM; Miner C; Lewinsohn DM; Sasaki AW; Kaufman E; Rosen HR
    Hepatology; 2003 Mar; 37(3):577-89. PubMed ID: 12601356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-derived hepatitis C virus inhibits CD4⁺ but not CD8⁺ T lymphocyte proliferation in primary T cells.
    MacParland SA; Chen AY; Corkum CP; Pham TN; Michalak TI
    Virol J; 2015 Jun; 12():93. PubMed ID: 26084511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virus-Specific Cellular Response in Hepatitis C Virus Infection.
    Kaźmierczak J; Caraballo Cortes K; Bukowska-Ośko I; Radkowski M
    Arch Immunol Ther Exp (Warsz); 2016 Apr; 64(2):101-10. PubMed ID: 26429740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of the virus specific T-cell response in acute and chronic HBV and HCV infection].
    Panther E; Spangenberg HC; Neumann-Haefelin C; Rösler K; Blum HE; von Weizsäcker F; Thimme R
    Z Gastroenterol; 2004 Jan; 42(1):39-46. PubMed ID: 14997402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immune cellular response in hepatitis C].
    López Labrador FJ
    Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():29-34. PubMed ID: 11279892
    [No Abstract]   [Full Text] [Related]  

  • 32. HIV-1 progression in hepatitis-C-infected drug users.
    Soriano V; Martín JC; González-Lahoz J
    Lancet; 2001 Apr; 357(9265):1361-2; author reply 1363. PubMed ID: 11347577
    [No Abstract]   [Full Text] [Related]  

  • 33. Characterization of HCV-specific Patr class II restricted CD4+ T cell responses in an acutely infected chimpanzee.
    Woollard DJ; Grakoui A; Shoukry NH; Murthy KK; Campbell KJ; Walker CM
    Hepatology; 2003 Nov; 38(5):1297-306. PubMed ID: 14578870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids.
    Geissler M; Gesien A; Tokushige K; Wands JR
    J Immunol; 1997 Feb; 158(3):1231-7. PubMed ID: 9013964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-hepatitis C virus T-cell immunity in the context of multiple exposures to the virus.
    Pfafferott K; Deshpande P; McKinnon E; Merani S; Lucas A; Heckerman D; Mallal S; John M; Gaudieri S; Lucas M
    PLoS One; 2015; 10(6):e0130420. PubMed ID: 26107956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What once was lost, now is found: restoration of hepatitis B-specific immunity after treatment of chronic hepatitis B.
    Koziel MJ
    Hepatology; 1999 Apr; 29(4):1331-3. PubMed ID: 10094984
    [No Abstract]   [Full Text] [Related]  

  • 37. Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees.
    Shata MT; Tricoche N; Perkus M; Tom D; Brotman B; McCormack P; Pfahler W; Lee DH; Tobler LH; Busch M; Prince AM
    Virology; 2003 Sep; 314(2):601-16. PubMed ID: 14554088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Robust and sustained immune activation in human Ebola virus infection.
    Mandl JN; Feinberg MB
    Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4518-9. PubMed ID: 25852148
    [No Abstract]   [Full Text] [Related]  

  • 39. [Changes of lymphocyte subsets in peripheral blood of patients with hepatitis C].
    Wan H; Li Y; Yang N; Yuan W; Xie N; Wang D; Guo T; Mao Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1058-61. PubMed ID: 25270208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.
    Grüner NH; Gerlach TJ; Jung MC; Diepolder HM; Schirren CA; Schraut WW; Hoffmann R; Zachoval R; Santantonio T; Cucchiarini M; Cerny A; Pape GR
    J Infect Dis; 2000 May; 181(5):1528-36. PubMed ID: 10823750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.